Literature DB >> 10051640

Analysis of masked mutations in familial adenomatous polyposis.

S J Laken1, N Papadopoulos, G M Petersen, S B Gruber, S R Hamilton, F M Giardiello, J D Brensinger, B Vogelstein, K W Kinzler.   

Abstract

Familial adenomatous polyposis (FAP) is an autosomal-dominant disease characterized by the development of hundreds of adenomatous polyps of the colorectum. Approximately 80% of FAP patients can be shown to have truncating mutations of the APC gene. To determine the cause of FAP in the other 20% of patients, MAMA (monoallelic mutation analysis) was used to independently examine the status of each of the two APC alleles. Seven of nine patients analyzed were found to have significantly reduced expression from one of their two alleles whereas two patients were found to have full-length expression from both alleles. We conclude that more than 95% of patients with FAP have inactivating mutations in APC and that a combination of MAMA and standard genetic tests will identify APC abnormalities in the vast majority of such patients. That no APC expression from the mutant allele is found in some FAP patients argues strongly against the requirement for dominant negative effects of APC mutations. The results also suggest that there may be at least one additional gene, besides APC, that can give rise to FAP.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051640      PMCID: PMC26782          DOI: 10.1073/pnas.96.5.2322

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of beta-catenin.

Authors:  S Kishida; H Yamamoto; S Ikeda; M Kishida; I Sakamoto; S Koyama; A Kikuchi
Journal:  J Biol Chem       Date:  1998-05-01       Impact factor: 5.157

2.  Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta.

Authors:  J Behrens; B A Jerchow; M Würtele; J Grimm; C Asbrand; R Wirtz; M Kühl; D Wedlich; W Birchmeier
Journal:  Science       Date:  1998-04-24       Impact factor: 47.728

3.  Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3beta and beta-catenin and inhibits axis formation of Xenopus embryos.

Authors:  H Yamamoto; S Kishida; T Uochi; S Ikeda; S Koyama; M Asashima; A Kikuchi
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

4.  Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta.

Authors:  M J Hart; R de los Santos; I N Albert; B Rubinfeld; P Polakis
Journal:  Curr Biol       Date:  1998-05-07       Impact factor: 10.834

5.  Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.

Authors:  S Ikeda; S Kishida; H Yamamoto; H Murai; S Koyama; A Kikuchi
Journal:  EMBO J       Date:  1998-03-02       Impact factor: 11.598

6.  Apc gene mutation is associated with a dominant-negative effect upon intestinal cell migration.

Authors:  N N Mahmoud; S K Boolbol; R T Bilinski; C Martucci; A Chadburn; M M Bertagnolli
Journal:  Cancer Res       Date:  1997-11-15       Impact factor: 12.701

7.  Dimer formation by an N-terminal coiled coil in the APC protein.

Authors:  G Joslyn; D S Richardson; R White; T Alber
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

8.  Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.

Authors:  P J Morin; A B Sparks; V Korinek; N Barker; H Clevers; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

9.  APC gene: database of germline and somatic mutations in human tumors and cell lines.

Authors:  P Laurent-Puig; C Béroud; T Soussi
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

10.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

View more
  20 in total

1.  A complex rearrangement in the APC gene uncovered by multiplex ligation-dependent probe amplification.

Authors:  Constanze Pagenstecher; Dorothea Gadzicki; Dietlinde Stienen; Siegfried Uhlhaas; Elisabeth Mangold; Nils Rahner; Mine Arslan-Kirchner; Peter Propping; Waltraut Friedl; Stefan Aretz
Journal:  J Mol Diagn       Date:  2007-02       Impact factor: 5.568

2.  Colorectal cancer: no longer the issue in familial adenomatous polyposis?

Authors:  Daniel C Gibbons; Ashish Sinha; Robin K S Phillips; Susan K Clark
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

3.  A comparison of the phenotype and genotype in adenomatous polyposis patients with and without a family history.

Authors:  Brindusa Truta; Brian A Allen; Peggy G Conrad; Vivian Weinberg; Glenn A Miller; Rob Pomponio; Lara R Lipton; Germano Guerra; Ian P M Tomlinson; Marvin H Sleisenger; Young S Kim; Jonathan P Terdiman
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 4.  Basic concepts for genetic testing in common hereditary colorectal cancer syndromes.

Authors:  Kristina Markey; Lisen Axel; Dennis Ahnen
Journal:  Curr Gastroenterol Rep       Date:  2002-10

5.  Mutational analysis of OGG1, MYH, MTH1 in FAP, HNPCC and sporadic colorectal cancer patients: R154H OGG1 polymorphism is associated with sporadic colorectal cancer patients.

Authors:  I-J Kim; J-L Ku; H C Kang; J-H Park; K-A Yoon; Y Shin; H-W Park; S G Jang; S-K Lim; S Y Han; Y-K Shin; M R Lee; S-Y Jeong; H-R Shin; J S Lee; W-H Kim; J-G Park
Journal:  Hum Genet       Date:  2004-09-24       Impact factor: 4.132

6.  Familial adenomatous polyposis patients without an identified APC germline mutation have a severe phenotype.

Authors:  M L Bisgaard; R Ripa; A L Knudsen; S Bülow
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

Review 7.  [Hereditary colorectal cancer].

Authors:  G Möslein
Journal:  Chirurg       Date:  2008-11       Impact factor: 0.955

8.  Familial adenomatous polyposis at the Tel Aviv Medical Center: demographic and clinical features.

Authors:  P Rozen; Z Samuel; M Rabau; G Goldman; R Shomrat; C Legum; A Orr-Urtreger
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

Review 9.  Preventive surgery for colon cancer in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer syndrome.

Authors:  Gabriela Möslein; Steffen Pistorius; Hans-Detlev Saeger; Hans K Schackert
Journal:  Langenbecks Arch Surg       Date:  2003-03-27       Impact factor: 3.445

10.  Missense polymorphisms in the adenomatous polyposis coli gene and colorectal cancer risk.

Authors:  Sean P Cleary; Hyeja Kim; Marina E Croitoru; Mark Redston; Julia A Knight; Steven Gallinger; Robert Gryfe
Journal:  Dis Colon Rectum       Date:  2008-07-10       Impact factor: 4.585

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.